Lango Region Achieves Remarkable 9% Growth in Viral Load Suppression Over Five-Year Period

The Lango sub-region has witnessed a significant increase in Viral Load Suppression (VLS) over the past five years,” stated recent reports. “The suppression rate has risen to 94 percent between 2018 and 2022, in contrast to the previous ten years when the sub-region struggled to surpass a viral load suppression rate of 85 percent.” The…

Goalkeepers Report: Seven Innovations Could Save 2 Million Mothers and Babies by 2030

The Bill & Melinda Gates Foundation has just unveiled its seventh annual Goalkeepers Report, which illuminates the world’s collective shortcomings as we reach the midpoint in our pursuit of the United Nations Sustainable Development Goals (SDGs). It also highlights the potential for innovation and investment to drive progress, especially in combating the global crisis of…

Health Professionals Offer Guidance to Government Regarding Medical Outreach Initiatives

Health experts are urging the government to initiate medical camps at health centers, staffed with teams of healthcare professionals, as a means of alleviating the daily pressures on healthcare services,” advised Dr. Rosemary Byanyima, the acting Executive Director of Mulago National Referral Hospital. She made this call to action during a two-day AMDA Caravan Medical…

Integrating HIV and NCD Health Services Yields Promising Outcomes, Report Finds

The integration of health services for people living with HIV and noncommunicable diseases (NCDs) can significantly enhance health outcomes and generate substantial returns on investment, according to a new report titled Spending Wisely: Exploring the economic and societal benefits of integrating HIV/AIDS and NCDs service delivery . The report, launched by the NCD Alliance and RTI International…

Major Price Drop Announced for Bedaquiline, a Vital Drug in TB Treatment

In a significant development, the Stop TB Partnership’s Global Drug Facility (GDF) has declared substantial price reductions of up to 55% for bedaquiline, a crucial drug used in treating drug-resistant TB (DR-TB). The revised bedaquiline prices, obtained through an open and competitive tender, will be in effect until December 2024, benefiting the majority of low-…

Breakthrough Study Reveals Promising Biomarker for Vascular Dementia Prevention and Treatment

A groundbreaking research effort led by Geneva University Hospitals (HUG) and the University of Geneva (UNIGE) has provided fresh insights into age-related dementias, particularly vascular dementia – the second most common form after Alzheimer’s disease. The study spotlights the pivotal role of the brain molecule known as chemokine receptor 5 (CCR5) in the neuronal deterioration…